Cite
HARVARD Citation
Jandu, H. et al. (n.d.). PD-025Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jandu, H. et al. (n.d.). PD-025Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine. Annals of oncology. p. . [Online].